These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24915546)

  • 1. Mechanisms of drug-induced liver injury.
    Stephens C; Andrade RJ; Lucena MI
    Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):286-92. PubMed ID: 24915546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury.
    Laifenfeld D; Qiu L; Swiss R; Park J; Macoritto M; Will Y; Younis HS; Lawton M
    Toxicol Sci; 2014 Jan; 137(1):234-48. PubMed ID: 24136188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges.
    Jee A; Sernoskie SC; Uetrecht J
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemical, genetic and immunological basis of idiosyncratic drug-induced liver injury.
    Tailor A; Faulkner L; Naisbitt DJ; Park BK
    Hum Exp Toxicol; 2015 Dec; 34(12):1310-7. PubMed ID: 26614821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of quantitative systems pharmacology modeling in the prediction and explanation of idiosyncratic drug-induced liver injury.
    Woodhead JL; Watkins PB; Howell BA; Siler SQ; Shoda LKM
    Drug Metab Pharmacokinet; 2017 Feb; 32(1):40-45. PubMed ID: 28129975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced liver injury: Advances in mechanistic understanding that will inform risk management.
    Mosedale M; Watkins PB
    Clin Pharmacol Ther; 2017 Apr; 101(4):469-480. PubMed ID: 27861792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell death in drug-induced liver injury.
    Iorga A; Dara L
    Adv Pharmacol; 2019; 85():31-74. PubMed ID: 31307591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The primary role of hepatic metabolism in idiosyncratic drug-induced liver injury.
    Amacher DE
    Expert Opin Drug Metab Toxicol; 2012 Mar; 8(3):335-47. PubMed ID: 22288564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or Necrosis.
    Iorga A; Dara L; Kaplowitz N
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28486401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of idiosyncratic drug-induced liver injury.
    Uetrecht J
    Adv Pharmacol; 2019; 85():133-163. PubMed ID: 31307585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver injury caused by drugs: an update.
    Stirnimann G; Kessebohm K; Lauterburg B
    Swiss Med Wkly; 2010; 140():w13080. PubMed ID: 20927685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel T(H)17-type cell is rapidly increased in the liver in response to acetaminophen-induced liver injury: T(H)17 cells and the innate immune response.
    Zhu X; Uetrecht J
    J Immunotoxicol; 2013; 10(3):287-91. PubMed ID: 23039944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predose and Postdose Blood Gene Expression Profiles Identify the Individuals Susceptible to Acetaminophen-Induced Liver Injury in Rats.
    Lu X; Hu B; Zheng J; Ji C; Fan X; Gao Y
    PLoS One; 2015; 10(10):e0141750. PubMed ID: 26512990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Omics analysis of low dose acetaminophen intake demonstrates novel response pathways in humans.
    Jetten MJ; Gaj S; Ruiz-Aracama A; de Kok TM; van Delft JH; Lommen A; van Someren EP; Jennen DG; Claessen SM; Peijnenburg AA; Stierum RH; Kleinjans JC
    Toxicol Appl Pharmacol; 2012 Mar; 259(3):320-8. PubMed ID: 22285215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetaminophen hepatotoxicity without intentional overdose.
    Mege J
    Pa Med; 1999 Jun; 102(6):14-5. PubMed ID: 10399461
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanisms of adaptation and progression in idiosyncratic drug induced liver injury, clinical implications.
    Dara L; Liu ZX; Kaplowitz N
    Liver Int; 2016 Feb; 36(2):158-65. PubMed ID: 26484420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced liver injury: summary of a single topic clinical research conference.
    Watkins PB; Seeff LB
    Hepatology; 2006 Mar; 43(3):618-31. PubMed ID: 16496329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on drug induced liver injury.
    Rangnekar AS; Fontana RJ
    Minerva Gastroenterol Dietol; 2011 Jun; 57(2):213-29. PubMed ID: 21587150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactive Metabolites: Current and Emerging Risk and Hazard Assessments.
    Thompson RA; Isin EM; Ogese MO; Mettetal JT; Williams DP
    Chem Res Toxicol; 2016 Apr; 29(4):505-33. PubMed ID: 26735163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a novel mouse model of amodiaquine-induced liver injury with a delayed onset.
    Metushi IG; Cai P; Dervovic D; Liu F; Lobach A; Nakagawa T; Uetrecht J
    J Immunotoxicol; 2015; 12(3):247-60. PubMed ID: 25046026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.